Corey Mccann serves as Executive at Pear Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Corey Mccann has executed 5 insider transactions totaling $39.2K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 20, 2023 involved selling 34,731 shares valued at $39.2K.
Corey Mccann currently holds 8,210,834 shares of Pear Therapeutics, Inc. (PEAR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Corey Mccann has been a net seller of PEAR stock. They have purchased $0 and sold $39.2K worth of shares.
Corey Mccann's most recent insider trade was on Jan 20, 2023, when they sold 34,731 shares at $1.13 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 3, 2021 | PEAR | $0 | Award | 986,517 | $N/A | Discretionary |
| Dec 3, 2021 | PEAR | $0 | Award | 8,157,656 | $N/A | Discretionary |
| Dec 3, 2021 | PEAR | $0 | Award | 1,685,913 | $N/A | Discretionary |